HemoShear Therapeutics

📍 Charlottesville, United States🗓 Founded 2008👥 60 employees💰 Last funded May 2014
Biotechnology Research🌐 hemoshear.com
Website LinkedIn
HemoShear Therapeutics is a biotechnology company focused on discovering novel biological targets and developing drugs to treat children’s rare metabolic disorders. Our goal is to discover drugs that save the lives of children who are born with metabolic defects and are unable to sustain basic biochemical processes necessary for life. Our proprietary technology allows us to recapitulate diseases using tissue from livers of children born with genetic defects, interrogate the disrupted biochemical processes, explore drug intervention strategies, and select drug candidates that we believe have high probabilities of clinical success. HemoShear is markedly different from other biotechnology companies because of our proprietary human disease models and our ability to recreate and interpret complex human biology. We believe that no other company can match our ability to understand human hepatic, tumor, or vascular disease biology and translate those findings into discovery of safe and effective drug treatments. We are passionate about understanding disease biology and driven to discover drug treatments that improve health outcomes and save lives. For more information, see www.hemoshear.com.
3
Total investors
1
Early stage
1
Mid stage
1
Late stage
2008
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Investor activity2008–2014 · investors recorded per year
200812012120141
Recent (last 2y)Earlier
Frequently asked questions
Who invested in HemoShear Therapeutics?
HemoShear Therapeutics has 3 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did HemoShear Therapeutics last raise funding?
The most recent investment in HemoShear Therapeutics recorded on gritt.io was in May 2014.
When was HemoShear Therapeutics founded?
HemoShear Therapeutics was founded in 2008.
What industry is HemoShear Therapeutics in?
HemoShear Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is HemoShear Therapeutics based?
HemoShear Therapeutics is headquartered in Charlottesville, United States.